Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 25,000 | 34,000 | 33,000 | 27,000 | 18,000 |
| Gross Profit | 25,000 | 34,000 | 33,000 | 27,000 | 18,000 |
| Operating Expenses | 111,000 | 108,000 | 103,000 | 96,000 | 85,000 |
| Operating Income | -86,000 | -74,000 | -70,000 | -69,000 | -67,000 |
| Other Income | 8,000 | 7,000 | 5,000 | 2,000 | 0 |
| Pre-tax Income | -78,000 | -67,000 | -65,000 | -67,000 | -67,000 |
| Income Tax | 2,000 | N/A | 0 | 0 | 1,000 |
| Net Income Continuous | -80,000 | -67,000 | -65,000 | -67,000 | -68,000 |
| Net Income | $-80,000 | $-67,000 | $-65,000 | $-67,000 | $-68,000 |
| EPS Basic Total Ops | -1.09 | -0.92 | -0.90 | -0.93 | -0.96 |
| EPS Basic Continuous Ops | -1.10 | -0.92 | -0.90 | -0.93 | -0.96 |
| EPS Diluted Total Ops | -1.09 | -0.92 | -0.90 | -0.93 | -0.96 |
| EPS Diluted Continuous Ops | -1.10 | -0.92 | -0.90 | -0.93 | -0.96 |
| EBITDA(a) | $-88,000 | $-75,000 | $-68,000 | $-67,000 | $-64,000 |